Gilead Slams HHS' 'Perverse' Requests In HIV Drug IP Battle

By Tiffany Hu · July 27, 2020, 10:53 PM EDT

Gilead has fired back at the U.S. Department of Health and Human Services' requests to wipe out counterclaims against the agency in a patent dispute over an HIV treatment, calling the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

The United States of America v. Gilead Sciences, Inc. et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

November 06, 2019

Recent Articles By Tiffany

June 13, 2023
Spinal Device Co. Gets $6M Bond Cut In Trade Secrets Suit
March 27, 2023
Wholesaler To Pay $33.4M In Abbott Labs Test Strips TM Row
February 16, 2023
TTAB Won't Let Diagnostic Co. Register 'NF-Light' TM
February 07, 2023
Instacart Co-Founder Hit With TRO In Trade Secrets Fight
January 20, 2023
Brand Battles: Uber Tries To Drive Out 'Uberhorny' Dating TM
January 04, 2023
TTAB Rejects Health Care Co.'s TM As Descriptive
March 21, 2022
Justices Skip $420M Secrets Suit, 'Candy Colors' Fight & More
March 09, 2022
Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023
February 25, 2022
Brand Battles: BetterUp Takes Aim At 'BetterHelp' Trademark
February 08, 2022
Sun Pharma, Lupin Agree To Drop Eye Pain Patent Dispute